National Medical Care Inkomsten in het verleden
Verleden criteriumcontroles 2/6
National Medical Care is de winst gegroeid met een gemiddeld jaarlijks percentage van 28.1%, terwijl de Healthcare industrie de winst jaarlijks groeide met 20.3%. De inkomsten zijn gegroeid met een gemiddelde snelheid van 10.5% per jaar. Het rendement op eigen vermogen van National Medical Care is 17.8%, en het heeft een nettomarge van 22.5%.
Belangrijke informatie
28.1%
Groei van de winst
28.1%
Groei van de winst per aandeel
| Healthcare Groei van de industrie | 12.3% |
| Inkomstengroei | 10.5% |
| Rendement op eigen vermogen | 17.8% |
| Nettomarge | 22.5% |
| Laatste winstupdate | 30 Sep 2024 |
Recente prestatie-updates uit het verleden
National Medical Care's (TADAWUL:4005) Solid Earnings May Rest On Weak Foundations
Oct 29
We Think National Medical Care's (TADAWUL:4005) Robust Earnings Are Conservative
Mar 14Recent updates
National Medical Care's (TADAWUL:4005) Solid Earnings May Rest On Weak Foundations
Oct 29National Medical Care (TADAWUL:4005) Shareholders Will Want The ROCE Trajectory To Continue
Sep 25Analysts Are Updating Their National Medical Care Company (TADAWUL:4005) Estimates After Its Second-Quarter Results
Aug 06Getting In Cheap On National Medical Care Company (TADAWUL:4005) Is Unlikely
Jul 26National Medical Care Company's (TADAWUL:4005) Shares May Have Run Too Fast Too Soon
Apr 05We Think National Medical Care's (TADAWUL:4005) Robust Earnings Are Conservative
Mar 14National Medical Care (TADAWUL:4005) Is Very Good At Capital Allocation
Mar 13Some Confidence Is Lacking In National Medical Care Company's (TADAWUL:4005) P/E
Dec 27Returns On Capital Are Showing Encouraging Signs At National Medical Care (TADAWUL:4005)
Dec 05We Like These Underlying Return On Capital Trends At National Medical Care (TADAWUL:4005)
Aug 07Is National Medical Care Company (TADAWUL:4005) Worth ر.س107 Based On Its Intrinsic Value?
May 29Investors Will Want National Medical Care's (TADAWUL:4005) Growth In ROCE To Persist
May 08Investors Will Want National Medical Care's (TADAWUL:4005) Growth In ROCE To Persist
Dec 19A Look At The Fair Value Of National Medical Care Company (TADAWUL:4005)
Oct 19National Medical Care (TADAWUL:4005) Is Doing The Right Things To Multiply Its Share Price
Aug 15National Medical Care's (TADAWUL:4005) Returns On Capital Are Heading Higher
May 13Earnings Update: National Medical Care Company (TADAWUL:4005) Just Reported Its Annual Results And Analysts Are Updating Their Forecasts
Mar 03A Look At The Fair Value Of National Medical Care Company (TADAWUL:4005)
Feb 10Returns At National Medical Care (TADAWUL:4005) Appear To Be Weighed Down
Nov 10Returns On Capital At National Medical Care (TADAWUL:4005) Have Hit The Brakes
Jul 02Estimating The Intrinsic Value Of National Medical Care Company (TADAWUL:4005)
Apr 14Is National Medical Care Company (TADAWUL:4005) A Risky Dividend Stock?
Mar 25Will National Medical Care (TADAWUL:4005) Multiply In Value Going Forward?
Feb 23Update: National Medical Care (TADAWUL:4005) Stock Gained 25% In The Last Five Years
Feb 09
National Medical Care Company's (TADAWUL:4005) Stock Been Rising But Financials Look Weak: Should Shareholders Be Worried?
Jan 27Calculating The Fair Value Of National Medical Care Company (TADAWUL:4005)
Jan 14Is National Medical Care Company's (TADAWUL:4005) 3.8% Dividend Sustainable?
Dec 25Does National Medical Care's (TADAWUL:4005) Statutory Profit Adequately Reflect Its Underlying Profit?
Dec 10What Kind Of Shareholders Hold The Majority In National Medical Care Company's (TADAWUL:4005) Shares?
Nov 24Opbrengsten en kosten
Hoe National Medical Care geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Sep 24 | 1,221 | 274 | 174 | 0 |
| 30 Jun 24 | 1,171 | 288 | 150 | 0 |
| 31 Mar 24 | 1,119 | 266 | 132 | 0 |
| 31 Dec 23 | 1,082 | 241 | 124 | 0 |
| 30 Sep 23 | 1,034 | 233 | 94 | 0 |
| 30 Jun 23 | 997 | 202 | 110 | 0 |
| 31 Mar 23 | 968 | 196 | 103 | 0 |
| 31 Dec 22 | 918 | 170 | 98 | 0 |
| 30 Sep 22 | 882 | 151 | 104 | 0 |
| 30 Jun 22 | 857 | 142 | 94 | 0 |
| 31 Mar 22 | 843 | 131 | 93 | 0 |
| 31 Dec 21 | 845 | 136 | 88 | 0 |
| 30 Sep 21 | 844 | 122 | 99 | 0 |
| 30 Jun 21 | 845 | 105 | 104 | 0 |
| 31 Mar 21 | 828 | 100 | 113 | 0 |
| 31 Dec 20 | 809 | 97 | 107 | 0 |
| 30 Sep 20 | 780 | 95 | 86 | 0 |
| 30 Jun 20 | 740 | 95 | 78 | 0 |
| 31 Mar 20 | 724 | 83 | 72 | 0 |
| 31 Dec 19 | 708 | 80 | 73 | 0 |
| 30 Sep 19 | 705 | 65 | 73 | 0 |
| 30 Jun 19 | 707 | 60 | 72 | 0 |
| 31 Mar 19 | 737 | 67 | 76 | 0 |
| 31 Dec 18 | 764 | 62 | 81 | 0 |
| 30 Sep 18 | 810 | 81 | 92 | 0 |
| 30 Jun 18 | 842 | 96 | 92 | 0 |
| 31 Mar 18 | 859 | 95 | 96 | 0 |
| 31 Dec 17 | 855 | 85 | 100 | 0 |
| 30 Sep 17 | 817 | -8 | 125 | 0 |
| 30 Jun 17 | 806 | -7 | 126 | 0 |
| 31 Mar 17 | 849 | 33 | 119 | 0 |
| 31 Dec 16 | 901 | 50 | 124 | 0 |
| 30 Sep 16 | 931 | 155 | 90 | 0 |
| 30 Jun 16 | 945 | 153 | 91 | 0 |
| 31 Mar 16 | 913 | 136 | 95 | 0 |
| 31 Dec 15 | 879 | 131 | 87 | 0 |
| 30 Sep 15 | 853 | 106 | 96 | 0 |
| 30 Jun 15 | 820 | 102 | 94 | 0 |
| 31 Mar 15 | 772 | 91 | 94 | 0 |
| 31 Dec 14 | 734 | 95 | 81 | 0 |
| 30 Sep 14 | 703 | 106 | 70 | 0 |
| 30 Jun 14 | 660 | 103 | 58 | 0 |
| 31 Mar 14 | 623 | 94 | 42 | 0 |
| 31 Dec 13 | 586 | 92 | 38 | 0 |
Kwaliteitswinsten: 4005 heeft een hoog niveau van non-cash earnings.
Groeiende winstmarge: De huidige netto winstmarges (22.5%) 4005 } zijn lager dan vorig jaar (22.5%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: De winst van 4005 is de afgelopen 5 jaar aanzienlijk gegroeid met 28.1% per jaar.
Versnelling van de groei: De winstgroei van 4005 over het afgelopen jaar ( 17.8% ) ligt onder het 5-jarig gemiddelde ( 28.1% per jaar).
Winst versus industrie: De winstgroei 4005 over het afgelopen jaar ( 17.8% ) overtrof de Healthcare -sector 15.7%.
Rendement op eigen vermogen
Hoge ROE: Het Rendement op eigen vermogen ( 17.8% ) van 4005 wordt als laag beschouwd.